Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany152-62-5 Dydrogesterone 98%
Dydrogesterone
Dydrogesterone

152-62-5 Dydrogesterone 98%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2024-03-01

Product Details

  • Product NameDydrogesterone
  • CAS No.152-62-5
  • EINECS No.205-806-8
  • MFC21H28O2
  • MW312.45
  • AppearanceneatWhite to Light Yellow
  • Melting point 168-173°C
  • storage temp. 2-8°C
  • Boiling point 392.36°C (rough estimate)
  • density 1.0697 (rough estimate)

Company Profile Introduction

Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally.

Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 Biologics in the Domestic Market & RoW markets & they are the domestic leader in three biologics.

With 350+ brands, five R&D centers and 13 manufacturing facilities established across the country, we have ensured a strong presence not just in India but also outside India with a wide network across 70+ countries. Our API facilities ensures that our supply chain is vertically integrated providing flexibility over control of manufacturing. We have cemented strategic global partnerships that are a result of alliances with local and multi-national companies which are at the helm of leadership in key therapeutic areas. The key objective of our widespread presence across markets is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

Recommended supplier

Emcure Pharmaceuticals Pvt Ltd

1Y Maharashtra India
  • Since:2021-03-01
  • Address: Plot P-II, IT-BT Park, M.I.D.C., Hinjawadi, Pune, Maharashtra-411 057, India.
INQUIRY